US Patent RE49825 Piperidinyl nociceptin receptor compounds
Patent RE49825 was granted and assigned to ASTRAEA THERAPEUTICS, LLC on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+527 characters)
US Patent RE49825 Piperidinyl nociceptin receptor compounds
Article
Patent abstract
The present invention provides novel piperidinyl-containing nociceptin receptor ligand compounds and pharmaceutical compositions useful in the treatment of neurological diseases and conditions where such ligands mediate the negative effects of the condition. Such neurological diseases and conditions include acute and chronic pain, substance abuse/dependence, alcohol addiction, anxiety, depression, sleep disorders, gastrointestinal disorders, renal disorders, cardiovascular disorders and Parkinson's disease.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Michael Meyer0
Nurulain Zaveri0
Date of Patent
February 6, 2024
0Patent Application Number
172457000
Date Filed
April 30, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent RE49825 Piperidinyl nociceptin receptor compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.